New postpartum depression pill could be game changer Roshni Dhar17 Aug 2023 5:03 PM ISTThe U.S. Food and Drug Administration has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in...
Health Bulletin 16/August/2023 Roshni Dhar16 Aug 2023 5:21 PM ISTHere are the top health stories for the day:Mandatory generic prescriptions: IMA demands deferring implementation of NMC regulationsThe Indian Medical...
USFAD approves Zurzuvae for postpartum depression Roshni Dhar7 Aug 2023 4:29 PM ISTThe U.S. Food and Drug Administration has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in...
Biogen, Sage Therapeutics get USFDA nod for Zurzuvae for postpartum depression in women Ruchika Sharma6 Aug 2023 3:30 PM ISTCambridge: Biogen Inc. and Sage Therapeutics, Inc. have announced the U.S. Food and Drug Administration (FDA) has approved ZURZUVAE (zuranolone)...
FDA Approves Zuranolone as first Oral Treatment of Postpartum Depression Dr. Kamal Kant Kohli5 Aug 2023 11:30 AM ISTThe U.S. Food and Drug Administration has today approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum...
Medical Bulletin 31/July/2023 Roshni Dhar31 July 2023 3:15 PM ISTOverview Here are the top medical news for the day:Zuranolone a reliable drug for post partum depression Most new mothersexperience postpartum "baby...
Zuranolone a reliable drug for post partum depression Roshni Dhar31 July 2023 9:45 AM ISTMost new mothers experience postpartum "#depression #babyblues #postpartumdepressionMost new mothers experience postpartum & baby blues& after...
Patients taking Zuranolone for major depression symptoms showed quick mood improvements: Phase 3 trial Medha Baranwal30 Jun 2023 8:00 PM ISTUSA: A recent study published in The American Journal of Psychiatry supports the potential of zuranolone for treating a major depressive disorder in...
Biogen, Sage Therapeutics get USFDA priority review for depression drug Zuranolone Ruchika Sharma7 Feb 2023 1:15 PM ISTZuranolone is an oral neuroactive steroid (NAS) GABA-A receptor positive allosteric modulator (PAM).
Zuranolone found effective for postpartum depression in phase 3 study Dr. Kamal Kant Kohli6 Jun 2022 9:15 AM ISTCAMBRIDGE, Mass: Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) today announced that the Phase 3 SKYLARK Study of zuranolone,...
Zuranolone improves depression symptoms as early as 3 days, finds study Hina Zahid13 Oct 2021 9:00 AM ISTCAMBRIDGE, Mass. - An experimental neuroactive steroid Zuranolone improves symptoms of major depression and boosts quality of life as early as 3...
Zuranolone improves symptoms of Postpartum Depression, finds JAMA study Dr. Shravani Dali4 July 2021 9:15 PM ISTZuranolone (anti-depressive medication under the development of SAGE Therapeutics) when used in the treatment of postpartum depression was well...
